ARCHITECT REACTION VESSEL
Report
- Report Number
- 1415939-2009-00187
- Event Type
- Malfunction
- Date Received
- March 13, 2009
- Date of Event
- October 7, 2008
- Report Date
- October 7, 2008
- Manufacturer
- ABBOTT LABORATORIES
- Product Code
- JJE
- PMA / PMN Number
- K983212
- Removal / Correction Number
- 1415939-2/27/09-003-R
- Product Problem
- Yes
- Report Source
- Manufacturer report
- Reporter Location
- JA
- Reporter Occupation
- OTHER
Narratives
(B)(4). EVALUATION: THE INVESTIGATION UNIT HAS EVALUATED THIS CUSTOMER COMPLAINT AND HAS DETERMINED THAT IT IS NOT ASSOCIATED WITH REMEDIAL ACTION REPORTING NUMBER 1415939-2/27/09-003-R AND IS THEREFORE UNASSIGNED. THIS IS THE FINAL REPORT.
THIS IS AN INITIAL REPORT. AN INVESTIGATION IS IN PROCESS. A FINAL REPORT WILL BE SUBMITTED WHEN THE INVESTIGATION IS COMPLETE.
(B)(4). UPON FURTHER REVIEW, THE CUSTOMER ISSUE IS ASSOCIATED WITH REMEDIAL ACTION REPORTING NUMBER 1415939-2/27/09-003-R, AS THE LOT OF THE SUSPECT REACTION VESSEL WAS IN USE AT THE CUSTOMER FACILITY. AN INVESTIGATION IS IN PROCESS. A FINAL REPORT WILL BE SUBMITTED WHEN THE INVESTIGATION IS COMPLETE.
(B)(4). THE INVESTIGATION DETERMINED THE CAUSES OF THE INCREASE IN FREQUENCY OF STATIC DISCHARGE EVENTS WERE DUE TO THE ARCHITECT REACTION VESSELS (RVS) SUPPLIER'S MANUFACTURING MATERIAL AND MANUFACTURING PROCESSES. THE PREVIOUS INVESTIGATION IDENTIFIED RV LOTS MADE FROM A PARTICULAR POLYPROPYLENE RESIN LOT WERE RESPONSIBLE FOR A MAJORITY OF THE STATIC DISCHARGE EVENTS. ANALYSIS OF THIS RESIN LOT DETERMINED IT HAS UNIQUE COMPOSITIONAL AND ANALYTICAL CHARACTERISTICS WHEN COMPARED TO OTHER RESIN LOTS, WHICH FACILITATED THE BUILD-UP OF STATIC CHARGE ON THE RVS. THE PREVIOUS INVESTIGATION ALSO IDENTIFIED VARIABLES WITHIN THE SUPPLIERS' MOLDING MANUFACTURING PROCESS THAT CONTRIBUTED TO STATIC CHARGE VARIATION ACROSS RV LOTS. THE LATEST INVESTIGATION IDENTIFIED ADDITIONAL VARIABLES WITHIN THE SUPPLIERS MOLDING MANUFACTURING PROCESS. ABBOTT HAS IMPLEMENTED MORE STRINGENT STATIC CHARGE SAMPLING AND TESTING FOR ACCEPTANCE OF ALL INCOMING RV LOTS FROM OUR SUPPLIER. ABBOTT HAS WORKED IN CLOSE COLLABORATION WITH OUR SUPPLIERS TO ASSURE CONSISTENCY OF INCOMING RESIN MATERIAL, AND TO IMPROVE THE SUPPLIER'S MOLDING PROCESS TO REDUCE THE POTENTIAL GENERATION OF STATIC CHARGE.
IT WAS REPORTED THAT THE DEVICE WAS EXPLANTED AFTER AN IMPLANT DURATION OF APPROXIMATELY 4.2 MONTHS, DUE TO UNKNOWN REASONS. NO FURTHER DETAILS WERE PROVIDED. INFORMATION LEARNED FROM IMPLANT PATIENT REGISTRY.
PHARMACY EMPLOYEE WAS PACKAGING A MAIL ORDER PRESCRIPTION WHICH INCLUDED INSULIN SYRINGES AND RECEIVED A NEEDLE STICK WHILE ATTEMPTING TO BUBBLE WRAP THE PRODUCT. IT WAS DETERMINED THAT TWO -2- OF THE TEN -10- SYRINGES DID NOT HAVE THE PROTECTIVE CAP ON THE NEEDLE. BD INSULIN SYRINGE WITH ULTRA FINE NEEDLE, 8 MM, 31 GAUGE, 1 ML NDC# 08290-8418-01 LOT # 01725145. DATES OF USE: (B)(6)2010.
THE CUSTOMER STATED ERROR CODE 1007, UNABLE TO PROCESS TEST, ACTIVATED READ FAILURE WAS OCCURRING ON THE ARCHITECT I2000SR ANALYZER. THE ISSUE WAS RESOLVED AFTER THE REACTION VESSEL LOT WAS CHANGED. NO IMPACT TO PATIENT MANAGEMENT WAS REPORTED.
ON (B)(6) 2009, THE PT'S DIABETES EDUCATOR REPORTED THAT WHILE TRAINING THE PT ON THE INFUSION DEVICE, THE PLUNGER OF THE INSULIN CARTRIDGE BECAME STUCK TO THE PISTON ROD OF THE INFUSION DEVICE. SHE STATED THAT APPROXIMATELY 280 UNITS OF INSULIN SPILLED IN THE CARTRIDGE COMPARTMENT OF THE INFUSION DEVICE. THE DIABETES EDUCATOR AND THE PT WERE EDUCATED ON THE PROPER PROCEDURE FOR REMOVING THE INSULIN CARTRIDGE FROM THE INFUSION DEVICE. NO PHYSIOLOGICAL EFFECTS WERE REPORTED. THE PT DID NOT REQUIRE MEDICAL ASSISTANCE FROM A HEALTHCARE PROFESSIONAL OR SECOND PARTY TO ADDRESS THE ISSUE. THE INFUSION DEVICE WAS REPLACED AND REQUESTED TO BE RETURNED FOR EVALUATION.
Devices
| Seq | Brand | Generic | Product Code | Manufacturer | Model | Lot | UDI-DI |
|---|---|---|---|---|---|---|---|
| 1 | ARCHITECT REACTION VESSEL | REACTION VESSELS FOR CHEMILUMINESCENT MICROPARTICLE IMMUNOASSAYS | JJE | ABBOTT LABORATORIES | 65386P100 |
Patients
| Seq | Age | Sex | Outcome | Treatment |
|---|---|---|---|---|
| 1 | ARCHITECT I2000SR |